LPA5 antagonist 2
LPA5 antagonist 2 (compound 65) is a high aqueous solubility LPA5 (lysophosphatidic acid receptor 5) antagonist. LPA5 antagonist 2 significantly attenuates nociceptive hypersensitivity and it can be used for the research of inflammatory and neuropathic pains[1].
Product Specifications
CAS Number
[2839471-44-0]
UNSPSC
12352005
Target
LPL Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/lpa5-antagonist-2.html
Purity
99.62
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1N(C2=CC=C3C(C(C)=CS3)=C2)C=C(C(N4CCC(F)CC4)=O)C5=C1C=C(OC)C(OC)=C5
Molecular Formula
C26H25FN2O4S
Molecular Weight
480.55
References & Citations
[1]Zhang DH, et al. Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2022.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15172301 1 Vial
Lentiviral mouse Mlkl shRNA (UAS) - Lentiviral mouse Mlkl shRNA (UAS) (25)
Ask
View Details 
GTR15308590 1 Vial
Lentiviral human FLCN shRNA (UAS) - Lentiviral human FLCN shRNA (UAS) plasmid
Ask
View Details 